Tax Structuring

Life sciences companies face complex tax considerations at every stage of growth, from early-stage research and development through commercialization, expansion, strategic partnerships, and exit transactions. Our tax team advises biotechnology, pharmaceutical, medical device, healthcare technology, and specialty healthcare companies on entity formation and structuring and multistate tax planning. Our team also helps companies maximize available federal, state, and local tax incentives, including research and development-related benefits, while aligning tax strategies with business objectives and operational realities in an effort to avoid unexpected and unintended tax liabilities.